abstract |
The invention relates to antibiotic suppositories which, in order to achieve microbial activity, a suitable bioavailability and a good local and general tolerance, consist of 0.103 g of erythromycin lactobionate, 0.07 g of erythromycin propionate, 0.00025 g of lauryl sulfate of sodium for a 1g suppository embedded in a known base. |